BCRX logo

BIOCRYST PHARMACEUTICALS INC

BCRXNASDAQ
🏆 #1605 by market capEarnings Nov 2US Equity
$10.22▼ $0.12 (−1.16%)
Live
1h▼ 0.8%
24h▼ 1.2%
7d▲ 12.7%
14d▲ 7.3%
30d▲ 3.1%
1y▲ 22.3%
🏦Market Cap
$2.60B
Small Cap
📈Revenue Growth (YoY)
+68.7%
High Growth
📊Gross Margin
97.8%
High
💵FCF Margin
47.9%
Strong
⚖️P/S Ratio
2.6x
Cheap
Otter Score
59
Weak
📊

Analyst Ratings

Price
$10.22
Total
29
Raised
7
Lowered
1
Avg PT
$20.00
H / L
$29 / $14
InstitutionActionRatingDate
Wedbush
ReiteratedOutperform2026-08-06
RBC Capital
ReiteratedOutperform2026-08-06
HC Wainwright & Co.
ReiteratedBuy2026-06-30
Cantor Fitzgerald
ReiteratedOverweight2026-06-30
Citizens
ReiteratedMarket Outperform2026-05-07
Needham
ReiteratedBuy2026-05-06
Barclays
ReiteratedEqual Weight2025-11-04
JMP Securities
ReiteratedMarket Outperform2025-10-15
B of A Securities
ReiteratedBuy2025-07-01
JP Morgan
ReiteratedOverweight2025-05-06
Citizens Capital Markets
ReiteratedMarket Outperform2025-03-03
Evercore ISI Group
ReiteratedOutperform2025-01-13
Jefferies
UpgradedHold → Buy2023-08-04
Oppenheimer
DowngradedOutperform → Perform2022-08-08
BTIG
ReiteratedNeutral2020-06-17
Bank of America
UpgradedNeutral → Buy2019-11-15
Seaport Global
ReiteratedNeutral2018-06-22
Ladenburg Thalmann
ReiteratedBuy2017-02-16
PiperJaffray
UpgradedNeutral → Overweight2016-08-12
Piper Sandler
UpgradedNeutral → Overweight2016-08-12
Rodman & Renshaw
ReiteratedBuy2016-02-09
FBR Capital
ReiteratedOutperform2015-04-21
Wells Fargo
UpgradedMarket Perform → Outperform2014-06-23
Brinson Patrick
ReiteratedMarket Outperform → Outperform2014-04-14
H.C. Wainwright
ReiteratedBuy2014-03-10
McNicoll Lewis Vlak
ReiteratedBuy2014-03-04
Roth Capital
ReiteratedBuy2014-01-21
Noble Capital Markets
UpgradedHold → Buy2013-07-23
Noble Financial
UpgradedHold → Buy2013-07-23
One row per institution, most recent rating